MDA-19 is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB2 with reasonable selectivity over the psychoactive CB1 receptor though with some variation between species. In animal studies it was effective for the treatment of neuropathic pain but failed to produce cannabis-like behavioural effects.
This page contains content from the copyrighted Wikipedia article "MDA-19"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
